Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid..
J Bone Miner Metab. 28(3), 314-9.
(2010). Comment on: Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients..
Oral Oncol. 45(6), e38; author reply e39.
(2009). The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone..
Horm Metab Res. 41(11), 846-50.
(2009). The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis..
Int J Cancer. 125(7), 1705-9.
(2009). Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib..
Clin Cancer Res. 15(23), 7153-60.
(2009). Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw..
J Clin Oncol. 27(32), 5356-62.
(2009). Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid..
Support Care Cancer. 17(10), 1329-30.
(2009). Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone..
J Bone Miner Metab. 26(6), 635-41.
(2008). Paget disease of the spine manifested by thoracic and lumbar epidural lipomatosis: magnetic resonance imaging findings..
Spine (Phila Pa 1976). 32(25), E789-92.
(2007). Persistent effect of zoledronic acid in Paget's disease..
Clin Exp Rheumatol. 25(3), 464-6.
(2007).